학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 1,843건 | 목록 1~10
Academic Journal
González-Martín A; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Rubio MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Reina Sofia University Hospital of Cordoba, Cordoba, Spain.; Heitz F; Department for Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynaecology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany.; Depont Christensen R; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy.; Van Gorp T; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Romeo M; Medical Oncology Department, Institut Català d'Oncologia, Institut Germans Trias i Pujol (IGTP), Badalona, Spain.; Centre Leon Bérard and University of Lyon, Lyon, France.; Ray-Coquard I; Centre Leon Bérard and University of Lyon, Lyon, France.; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Gaba L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Leary A; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Gustave Roussy, Villejuif, France.; De Sande LM; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Complejo Asistencial Universitario de León, León, Spain.; Lebreton C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Department-Gynecologic Group, Institut Bergonié-Centre Régional de Lutte Contre le Cancer (CLCC), Bordeaux, France.; Redondo A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Fabbro M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France.; Barretina Ginesta MP; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, Institut Català d'Oncologia, IDIBGI, Girona, Spain.; Follana P; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Centre Antoine Lacassagne, Nice, France.; Pérez-Fidalgo JA; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Department, University Hospital of Valencia, INCLIVA Biomedical Research Institute, CIBERONC, Valencia, Spain.; Rodrigues M; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Curie, Paris, France.; Santaballa A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario La Fe, Valencia, Spain.; Sabatier R; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Institut Paoli Calmettes, Marseille, France.; Bermejo-Pérez MJ; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.; Lotz JP; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Sorbonne Université, Paris, France.; Pardo B; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Marquina G; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Department of Medical Oncology, Department of Medicine, Hospital Clínico San Carlos, School of Medicine, Instituto de Investigación Sanitaria (IdISSC), EURACAN Referral Centre, Universidad Complotense de Madrid (UCM), Madrid, Spain.; Sánchez-Lorenzo L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Clínica Universidad de Navarra, Madrid, Spain.; Quindós M; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; A Coruña Biomedical Research Institute (INIBIC), A Coruña University Hospital, A Coruña, Spain.; Estévez-García P; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Virgen del Rocío and Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.; Guerra Alía E; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Ramón y Cajal, Madrid, Spain.; Manso L; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain.; Casado V; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain.; Kommoss S; Arbeitsgemeinschaft Gynaekologische Onkologie (AGO), Wiesbaden, Germany.; Universitätsklinikum Tübingen, Universitätsfrauenklinik, Tübingen, Germany.; Current address: Diakonie-Klinikum Schwäbisch Hall gGmbH, Schwäbisch Hall, Germany.; Tognon G; Mario Negri Gynecologic Oncology Group (MaNGO), Milan, Italy.; Spedali Civili di Brescia, Brescia, Italy.; Henry S; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; CHU UCL NAMUR (site Ste Elisabeth), Université Catholique de Louvain, Namur, Belgium.; Bruchim I; Gynecologic Oncology Department, Hillel Yaffe Medical Center, Affiliated with the Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Israeli Society of Gynecologic Oncology (ISGO), Ashkelon, Israel.; Oaknin A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain.; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Selle F; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Paris, France.; Medical Oncology Service, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Lorusso D; Gynaecology Oncology Unit, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Gynaecology Oncology Unit, Humanitas San Pio X, Milan, Italy. Electronic address: domenica.lorusso@hunimed.eu.; Xiang Y; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China.; Hasegawa K; Department of Obstetrics and Gynecology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.; Scambia G; Scientific Directorate, Fondazione Policlinico Universitario Agostino Gemelli IRCCS and Catholic University of the Sacred Heart, Rome, Italy.; Leiva M; Oncología Médica, Instituto Peruano de Oncología y Radioterapia, Lima, Perú.; Ramos-Elias P; Oncología Médica, Integra Cancer Institute, Edificio Integra Medical Center, Guatemala City, Guatemala.; Acevedo A; Oncocentro, Valparaiso, Chile.; Cvek J; Department of Oncology, University of Ostrava, North Moravia, Czech Republic.; Randall L; Gynecologic Oncology, Virginia Commonwealth University, Massey Comprehensive Cancer Center, Richmond, VA, USA.; Pereira de Santana Gomes AJ; Oncologia Clínica, Liga Norte Riograndense Contra o Cancer, Natal, Rio Grande do Norte, Brazil.; Contreras Mejía F; Oncología Clínica, Instituto Nacional de Cancerologia, Bogota, Colombia.; Helpman L; Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.; Akıllı H; Turkish Society of Gynecologic Oncology, Başkent University, Ankara, Turkiye.; Lee JY; Yonsei Cancer Center and Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.; Saevets V; Gynaecological Oncology, Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine, Chelyabinsk, Russia.; Zagouri F; Clinical Therapeutics, Alexandra Hospital, Athens, Greece.; Gilbert L; Division of Gynecologic Oncology, McGill University Health Centre, Research Institute-McGill University Health Centre, Gerald Bronfman Department of Oncology McGill University, Montreal, QC, Canada.; Sehouli J; Department of Gynecology, Charite Universitaetsmedizin, Berlin, Germany; North-Eastern German Society of Gynecological Oncology, Berlin, Germany.; Tharavichitkul E; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.; Lindemann K; Department of Gynecological Oncology, Oslo University Hospital and the Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Nordic Society of Gynaecological Oncology Clinical Trial Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Colombo N; Department of Obstetrics and Gynecology, University of Milan-Bicocca and European Institute of Oncology IRCCS, -Milan, Italy.; Chang CL; Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.; Bednarikova M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Zhu H; Department of Oncology, Xiangya Hospital, Central South University, Hunan, China.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Christiaens M; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.; Petru E; Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria; AGO-Austria, Innsbruck, Austria.; Usami T; Department of Obstetrics and Gynecology, Ehime University Hospital, Toon, Ehime, Japan.; Liu P; Merck & Co, Rahway, NJ, USA.; Yamada K; Merck & Co, Rahway, NJ, USA.; Toker S; Merck & Co, Rahway, NJ, USA.; Keefe SM; Merck & Co, Rahway, NJ, USA.; Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.; Duska LR; Gynelogic Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Birrer M; University of Arkansas Medical Sciences, Little Rock.; Li G; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China.; Yunokawa M; Cancer Institute Hospital of JFCR, Tokyo, Japan.; Lee JY; Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.; Kim BG; Samsung Medical Center, Seoul, Republic of Korea.; Oppermann CP; Hospital Mãe de Deus, Porto Alegre, Brazil.; Zhou Q; Chongqing University Cancer Hospital, Chongqing, China.; Nishio S; Kurume University School of Medicine, Fukuoka, Japan.; Okamoto A; Jikei University Hospital, Tokyo, Japan.; Wu X; Fudan University Shanghai Cancer Center, Shanghai, China.; Mileshkin L; Peter MacCallum Cancer Centre, Melbourne, Australia.; Oaknin A; Gynaecologic Cancer Programme Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Ray-Coquard I; Centre Léon Bérard, University Claude Bernard Lyon 1, Lyon, France.; Hasegawa K; Saitama Medical University International Medical Center, Saitama, Japan.; Jehl G; the healthcare business of Merck KGaA, Darmstadt, Germany.; Vugmeyster Y; EMD Serono, Billerica, Massachusetts.; Zhang S; EMD Serono, Billerica, Massachusetts.; Now with Theseus Pharmaceuticals, Cambridge, Massachusetts.; Bajars M; the healthcare business of Merck KGaA, Darmstadt, Germany.; Yonemori K; National Cancer Center Hospital, Tokyo, Japan.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.; Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France.; Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain.; Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com.; Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France.; Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France.; Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain.; Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain.; Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.; Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain.; Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.; Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain.; Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com.; Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain.; Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Oaknin, A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어